Ryan Lahey1, Sadiya S Khan2,3. 1. Department of Medicine, Northwestern University Feinberg School of Medicine. 2. Division of Cardiology, Department of Medicine, Northwestern University Feinberg School of Medicine. 3. Department of Preventive Medicine, Northwestern University Feinberg School of Medicine.
Abstract
PURPOSE OF REVIEW: The obesity epidemic is a global health crisis of staggering proportion. Excess body weight is a major risk factor for the development of cardiovascular disease (CVD). We review temporal trends in obesity rates, pertinent pathophysiology to understand mechanisms of disease, and treatment strategies in the context of reducing cardiovascular risk. RECENT FINDINGS: The prevalence of obesity is increasing in recent decades and is driven by a complex interplay of economic, environmental, and biological factors. In developed countries, changes in foodintake, such as increased consumption of energy-dense and added sugar have contributed significantly to weight gain. Single nucleotide variations in genes and alterations in the gut microbiome have been associated with the obese phenotype. The description of an obesity paradox in patients with CVD may have several explanations, including limitations of body mass index (BMI) to assess adiposity, selection bias, and lead-time bias with earlier onset of disease. Evidence-based treatments for weight loss include lifestyle intervention, pharmacotherapy, and bariatric surgery. Data on the long-term effects of these therapies on cardiovascular risk are limited. SUMMARY: Overweight and obesity are associated with increased cardiovascular morbidity and mortality over the lifespan. Despite our increasing understanding of biological and environmental drivers of obesity, more work is needed in developing effective prevention strategies and implementation of evidence-based treatments to promote cardiovascular health and reduce cardiovascular risk. Ultimately, efforts to prevent and postpone cardiovascular morbidity should include focus on maintenance of normal BMI (primordial prevention) for a longer and healthier life, free of CVD.
PURPOSE OF REVIEW: The obesity epidemic is a global health crisis of staggering proportion. Excess body weight is a major risk factor for the development of cardiovascular disease (CVD). We review temporal trends in obesity rates, pertinent pathophysiology to understand mechanisms of disease, and treatment strategies in the context of reducing cardiovascular risk. RECENT FINDINGS: The prevalence of obesity is increasing in recent decades and is driven by a complex interplay of economic, environmental, and biological factors. In developed countries, changes in foodintake, such as increased consumption of energy-dense and added sugar have contributed significantly to weight gain. Single nucleotide variations in genes and alterations in the gut microbiome have been associated with the obese phenotype. The description of an obesity paradox in patients with CVD may have several explanations, including limitations of body mass index (BMI) to assess adiposity, selection bias, and lead-time bias with earlier onset of disease. Evidence-based treatments for weight loss include lifestyle intervention, pharmacotherapy, and bariatric surgery. Data on the long-term effects of these therapies on cardiovascular risk are limited. SUMMARY: Overweight and obesity are associated with increased cardiovascular morbidity and mortality over the lifespan. Despite our increasing understanding of biological and environmental drivers of obesity, more work is needed in developing effective prevention strategies and implementation of evidence-based treatments to promote cardiovascular health and reduce cardiovascular risk. Ultimately, efforts to prevent and postpone cardiovascular morbidity should include focus on maintenance of normal BMI (primordial prevention) for a longer and healthier life, free of CVD.
Authors: Fahad Razak; Sonia S Anand; Harry Shannon; Vladimir Vuksan; Bonnie Davis; Ruby Jacobs; Koon K Teo; Matthew McQueen; Salim Yusuf Journal: Circulation Date: 2007-04-09 Impact factor: 29.690
Authors: Christopher G Owen; Richard M Martin; Peter H Whincup; George Davey Smith; Derek G Cook Journal: Pediatrics Date: 2005-05 Impact factor: 7.124
Authors: Peter J Turnbaugh; Ruth E Ley; Michael A Mahowald; Vincent Magrini; Elaine R Mardis; Jeffrey I Gordon Journal: Nature Date: 2006-12-21 Impact factor: 49.962
Authors: C J Hukshorn; F M H van Dielen; W A Buurman; M S Westerterp-Plantenga; L A Campfield; W H M Saris Journal: Int J Obes Relat Metab Disord Date: 2002-04
Authors: Earl S Ford; Umed A Ajani; Janet B Croft; Julia A Critchley; Darwin R Labarthe; Thomas E Kottke; Wayne H Giles; Simon Capewell Journal: N Engl J Med Date: 2007-06-07 Impact factor: 91.245
Authors: I Sadaf Farooqi; Edward Bullmore; Julia Keogh; Jonathan Gillard; Stephen O'Rahilly; Paul C Fletcher Journal: Science Date: 2007-08-09 Impact factor: 47.728
Authors: Costela Lăcrimioara Șerban; Alexandra Sima; Corina Marcela Hogea; Adela Chiriță-Emandi; Iulia Teodora Perva; Adrian Vlad; Alin Albai; Georgiana Nicolae; Salomeia Putnoky; Romulus Timar; Mihai Dinu Niculescu; Maria Puiu Journal: Int J Environ Res Public Health Date: 2019-08-22 Impact factor: 3.390
Authors: David E Stec; Darren M Gordon; Andrea L Nestor-Kalinoski; Matthew C Donald; Zachary L Mitchell; Justin F Creeden; Terry D Hinds Journal: Biomolecules Date: 2020-03-02